RankAlpha logo
Back to Rankings

LBRX

LBC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
LBRX vs peer average
48/100
LBRX vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 4 · D 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ABUS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $900.77M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerABUSArbutus Biopharma
LBRX
LB
ABUS
Arbutus Biopharma
Grade
C
C
Momentum
64
46
Value
46
41
Sentiment
-
67
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs ABUS

LBRX / ABUS
Grade Position
In line
LBRX vs. peer average (C vs. C)
48/100
Momentum
64
LBRX
Value
46
LBRX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LBRX
1
ABUS
Arbutus Biopharma Corp Common
C
60/100
Even
2
GERN
Geron Corp Common
A
100/100
-2
3
DBVT
DBV Technologies SA ADR
C
60/100
Even
4
TBPH
Theravance Biopharma Inc Common
D
40/100
+1
5
SANA
Sana Biotechnology Inc Common
C
60/100
Even
ABUS is the first peer returned for this comparison set.